Nanotech Business Japan-Netherlands Webinar 2020

BIOSENSORS AND THE IMPORTANCE OF SURFACE FUNCTIONALIZATION

The battle against Covid-19 has stressed the importance of virus detection and put the spotlight on promising biosensor technology to perform such tasks more efficiently and with greater accuracy. Biosensors have a host of roles to play in biometric monitoring and disease detection. A vital aspect of this technology is surface functionalization to enable target isolation, sensitivity and specificity.

Agenda:

• 08:00 CET / 16:00 JST opening
• Moderated by Raoul Oostenbrink, Coordinator Business Cluster Nanotechnology
• Opening: Eric van Kooij, Innovation Councellor, Embassy of the Kindom of the Netherlands
• Keynote: Prof. Albert van den Berg, Nano4Society
• Presentation: Prof. Yoshinobu Baba, Nagoya University
• Presentation: LipoCoat, Surfix, VSParticle, DoMicro, Holst Centre
• Q&A
• Close

Albert van den Berg

Albert van den Berg received his MSc in applied physics in 1983, and his PhD in 1988 both at the University of Twente, the Netherlands. From 1988-1993 he worked in Neuchatel, Switzerland, at the CSEM and the University (IMT) on miniaturized chemical sensors. In 2000 he was appointed as full professor on Miniaturized Systems for (Bio)Chemical Analysis in the faculty of Electrical Engineering and part of the MESA+ Institute for Nanotechnology. In 1994 he initiated together with Prof. Bergveld the international MicroTAS conference series. He published over 450 peer reviewed publications (H=63 WoS, H=85 Google Scholar) a.o. in Science, Nature, PNAS, NanoLetters etc, and from his group > 10 spin-o companies started. He received several honors and awards such two ERC Advanced (2008, 2015) and four ERC Proof of Concept (2011, 2013, 2016, 2020) grants, Simon Stevin award (engineering sciences, 2002), Spinoza prize (2009), Distinguished University Professor (Twente, 2010), Distinguished Professor (South China Normal University SNCU (China), 2012), Consulting Professor at Northwestern Polytechnic University NPU (China), 2017) and member of the Royal Dutch Academy of Sciences (KNAW) (board member from 2011-2016). He is member of the Koninklijke Hollandse Maatschappij van Wetenschappen (KHMW), the Academy for Technology and Innovation (ACTI), and founding member of HDMT and EUROoCS, the European Organ on Chip Society. From 2014-2018 he
was scientific director of the MIRA institute for Biomedical Engineering. In 2017 he became co-PI of the Max Planck – University of Twente Center for Complex Fluid Dynamics. In 2018 he became (co)director of MESA+ institute for Nanotechnology. He has been editor of Sensors and Actuators B, cofounding member of the editorial board of the RSC journal Lab on a Chip, and founding director of the CBMS, the Chemical and Biological Microsystems Society.

Yoshinobu Baba

Dr. Yoshinobu Baba received PhD degree in 1986 from Kyushu University. Aer Assistant Professor at Oita University and Associate Professor at Kobe Pharmaceutical University, he was promoted to the full professor at The University of Tokushima in 1997. He was moved to Nagoya University in 2004. He is now a Professor of Department of Chemistry and Biotechnology, School of Engineering, a Professor of Department of Advanced Medical Science, School of Medicine, and a Director of Institute of Nano-Life-Systems, Nagoya University. He is also a Director of Institute of Quantum Life Science, National Institutes for Quantum and Radiological Science and Technology, and a Research Supervisor, JST CREST “Extracellular fine particles” Project. He is a co-initiator for the world largest Nanotech International Meeting. He is a general chair of numerous international meetings (microTAS, MSB, nanotech, ISMM). He is an Associate Editor of Anal. Chem. of ACS and serving to over 10 scientific journals as an editorial/advisory board member. He has been admitted as a Fellow of the Royal Society of Chemistry and received over 90 awards for his contributions in nanobiotechnology. Dr. Baba’s research studies are directed at the development of nanobiodevices for omics, systems biology, medical diagnosis, tissue engineering, and molecular imaging. He is the
author or co-author of 1,027 publications, including research papers,  proceedings, reviews, and books and is also an inventor of over 100 patents. He has delivered more than 1,010 plenary and invited lectures at conferences. His work has been cited on 484 occasions by newspapers and television.